Efficacy and safety of the ROCK2-inhibitor belumosudil for chronic GVHD: results from a multicenter retrospective analysis of a large German-Austrian cohort of the belumosudil MAP.
U. Holtick
E. Sala
K. Egger-Heidrich
Mareike Verbeek
S. Heidenreich
Alexander Denk
Giuliano Filippini Velázquez
C. Rautenberg
H. Schmeller
Lasse Jost
T. Richardson
Christof Scheid
K. Strauss
F. Taube
Katharina Nickel
Christoph Schmid
Sara Jennrich
T. Holderried
F. Stölzel
L. Steiner
M. Dohse
Mohamad-Kamal Yaakoub
N. Steiner
Olaf Penack
Darina Kodzhabasheva
Jochen J. Frietsch
Matthias Stelljes
Caroline Pabst
Ina Rudolph
Guido Kobbe
C. Wehr
K. Maas-Bauer
R. Zeiser
Daniel Wolff
Matthias A. Fante
Medicine